Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription.

Hua G, He C, Lv X, Fan L, Wang C, Remmenga SW, Rodabaugh KJ, Yang L, Lele SM, Yang P, Karpf AR, Davis JS, Wang C.

Cell Death Dis. 2016 Jul 14;7:e2297. doi: 10.1038/cddis.2016.207.

2.

The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression.

He C, Mao D, Hua G, Lv X, Chen X, Angeletti PC, Dong J, Remmenga SW, Rodabaugh KJ, Zhou J, Lambert PF, Yang P, Davis JS, Wang C.

EMBO Mol Med. 2015 Nov;7(11):1426-49. doi: 10.15252/emmm.201404976.

3.

Blueprint for success: translating innovations from the field of palliative medicine to the medical-legal partnership.

Hallarman L, Snow D, Kapoor M, Brown C, Rodabaugh K, Lawton E.

J Leg Med. 2014;35(1):179-94. doi: 10.1080/01947648.2014.885330. No abstract available.

PMID:
24669813
4.

We need a new paradigm in gynecologic cancer care: SGO proposes solutions for delivery, quality and reimbursement policies.

Alvarez RD, Gray HJ, Timmins PF 3rd, Gibb RK, Edelson M, Fowler JM, Havrilesky LJ, McCauley DL, Nash JD, Rahaman J, Rash JK, Rodabaugh KJ, Powell MA, Bristow RE, Brown JV, Tewari D, Cliby WA, Anastasia P, Robinson WR 3rd, Shahin MS, Cantrell LA, Cloven NG, Gold MA, Hope JM, Muntz HG, Sorosky JI, Elkas JC, Frumovitz MM, Jewell E, Spillman MA, Naumann RW.

Gynecol Oncol. 2013 Apr;129(1):3-4. No abstract available.

PMID:
23638463
5.

Instituting a robot-assisted surgery programme at a tertiary care cancer centre.

duPont NC, Guru KA, Iskander GB, Odunsi K, Lele SB, Rodabaugh KJ.

Int J Med Robot. 2010 Sep;6(3):330-3. doi: 10.1002/rcs.339.

PMID:
20629199
6.

Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation.

McCloskey SA, Tchabo NE, Malhotra HK, Odunsi K, Rodabaugh K, Singhal P, Lele S, Jaggernauth W.

Gynecol Oncol. 2010 Mar;116(3):404-7. doi: 10.1016/j.ygyno.2009.06.027. Epub 2009 Nov 27.

PMID:
19944453
7.

A medical-legal partnership as a component of a palliative care model.

Rodabaugh KJ, Hammond M, Myszka D, Sandel M.

J Palliat Med. 2010 Jan;13(1):15-8. doi: 10.1089/jpm.2009.0203.

PMID:
19827963
8.

A study of pyrimidine base damage in relation to oxidative stress and cancer.

Iijima H, Patrzyc HB, Budzinski EE, Freund HG, Dawidzik JB, Rodabaugh KJ, Box HC.

Br J Cancer. 2009 Aug 4;101(3):452-6. doi: 10.1038/sj.bjc.6605176. Epub 2009 Jul 14.

9.

Consideration of hereditary nonpolyposis colorectal cancer in BRCA mutation-negative familial ovarian cancers.

South SA, Vance H, Farrell C, DiCioccio RA, Fahey C, Piver MS, Rodabaugh KJ.

Cancer. 2009 Jan 15;115(2):324-33. doi: 10.1002/cncr.24012.

10.

Higher regular coffee and tea consumption is associated with reduced endometrial cancer risk.

McCann SE, Yeh M, Rodabaugh K, Moysich KB.

Int J Cancer. 2009 Apr 1;124(7):1650-3. doi: 10.1002/ijc.24125.

11.

Higher intakes of vegetables and vegetable-related nutrients are associated with lower endometrial cancer risks.

Yeh M, Moysich KB, Jayaprakash V, Rodabaugh KJ, Graham S, Brasure JR, McCann SE.

J Nutr. 2009 Feb;139(2):317-22. doi: 10.3945/jn.108.099960. Epub 2008 Dec 11.

PMID:
19074206
12.

The use of array-based comparative genomic hybridization (a-CGH) to distinguish metastatic from primary synchronous carcinomas of the ovary and the uterus.

Mhawech-Fauceglia P, Rai H, Nowak N, Cheney RT, Rodabaugh K, Lele S, Odunsi K.

Histopathology. 2008 Oct;53(4):490-5. doi: 10.1111/j.1365-2559.2008.03107.x. Epub 2008 Jul 16. No abstract available.

PMID:
18643851
13.

Intraobserver and interobserver variability in distinguishing between endocervical and endometrial adenocarcinoma on problematic cases of cervical curettings.

Mhawech-Fauceglia P, Herrmann F, Bshara W, Zhang S, Penetrante R, Lele S, Odunsi K, Rodabaugh K.

Int J Gynecol Pathol. 2008 Jul;27(3):431-6. doi: 10.1097/PGP.0b013e3181601792.

PMID:
18580323
14.

Desmoplastic small round cell tumor (DSRCT) with ovarian involvement in 2 young women.

Fang X, Rodabaugh K, Penetrante R, Wong M, Wagner T, Sait S, Mhawech-Fauceglia P.

Appl Immunohistochem Mol Morphol. 2008 Jan;16(1):94-9.

PMID:
18091312
15.

Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.

Lu KH, Schorge JO, Rodabaugh KJ, Daniels MS, Sun CC, Soliman PT, White KG, Luthra R, Gershenson DM, Broaddus RR.

J Clin Oncol. 2007 Nov 20;25(33):5158-64. Epub 2007 Oct 9.

PMID:
17925543
16.

Uterine carcinosarcoma associated with hereditary nonpolyposis colorectal cancer.

South SA, Hutton M, Farrell C, Mhawech-Fauceglia P, Rodabaugh KJ.

Obstet Gynecol. 2007 Aug;110(2 Pt 2):543-5.

PMID:
17666659
17.

Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer.

Odunsi K, Qian F, Matsuzaki J, Mhawech-Fauceglia P, Andrews C, Hoffman EW, Pan L, Ritter G, Villella J, Thomas B, Rodabaugh K, Lele S, Shrikant P, Old LJ, Gnjatic S.

Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12837-42. Epub 2007 Jul 25.

18.

Expression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression.

Sood AK, Saxena R, Groth J, Desouki MM, Cheewakriangkrai C, Rodabaugh KJ, Kasyapa CS, Geradts J.

Hum Pathol. 2007 Nov;38(11):1628-38. Epub 2007 May 22.

19.

Medically related legal needs and quality of life in cancer care: a structural analysis.

Zevon MA, Schwabish S, Donnelly JP, Rodabaugh KJ.

Cancer. 2007 Jun 15;109(12):2600-6.

20.

Usual adult body mass index is not predictive of ovarian cancer survival.

Moysich KB, Baker JA, Menezes RJ, Jayaprakash V, Rodabaugh KJ, Odunsi K, Beehler GP, McCann SE, Villella JA.

Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):626-8. No abstract available.

21.

Consumption of black tea or coffee and risk of ovarian cancer.

Baker JA, Boakye K, McCann SE, Beehler GP, Rodabaugh KJ, Villella JA, Moysich KB.

Int J Gynecol Cancer. 2007 Jan-Feb;17(1):50-4.

PMID:
17291231
22.

Prostate-derived Ets factor is overexpressed in serous epithelial ovarian tumors.

Rodabaugh KJ, Mhawech-Fauceglia P, Groth J, Lele S, Sood AK.

Int J Gynecol Pathol. 2007 Jan;26(1):10-5. Erratum in: Int J Gynecol Pathol. 2007 Apr;26(2):205.

PMID:
17197890
23.

The role of hereditary nonpolyposis colorectal cancer in the management of familial ovarian cancer.

Farrell C, Lyman M, Freitag K, Fahey C, Piver MS, Rodabaugh KJ.

Genet Med. 2006 Oct;8(10):653-7.

PMID:
17079882
24.

Risk of ovarian cancer associated with BMI varies by menopausal status.

Beehler GP, Sekhon M, Baker JA, Teter BE, McCann SE, Rodabaugh KJ, Moysich KB.

J Nutr. 2006 Nov;136(11):2881-6.

PMID:
17056817
25.

Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer.

Sabbatini P, Dupont J, Aghajanian C, Derosa F, Poynor E, Anderson S, Hensley M, Livingston P, Iasonos A, Spriggs D, McGuire W, Reinartz S, Schneider S, Grande C, Lele S, Rodabaugh K, Kepner J, Ferrone S, Odunsi K.

Clin Cancer Res. 2006 Sep 15;12(18):5503-10.

26.

Primary fallopian tube carcinoma: a retrospective clinicopathologic study.

Singhal P, Odunsi K, Rodabaugh K, Driscoll D, Lele S.

Eur J Gynaecol Oncol. 2006;27(1):16-8.

PMID:
16550961
27.

Active and passive smoking and risk of ovarian cancer.

Baker JA, Odunuga OO, Rodabaugh KJ, Reid ME, Menezes RJ, Moysich KB.

Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:211-8.

PMID:
16515593
28.

Role of prophylactic hysterectomy in patients at high risk for hereditary cancers.

Villella JA, Parmar M, Donohue K, Fahey C, Piver MS, Rodabaugh K.

Gynecol Oncol. 2006 Sep;102(3):475-9. Epub 2006 Feb 13.

PMID:
16473397
29.

Regular analgesic use and risk of endometrial cancer.

Moysich KB, Baker JA, Rodabaugh KJ, Villella JA.

Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2923-8.

30.

A-kinase anchoring protein 3 messenger RNA expression correlates with poor prognosis in epithelial ovarian cancer.

Sharma S, Qian F, Keitz B, Driscoll D, Scanlan MJ, Skipper J, Rodabaugh K, Lele S, Old LJ, Odunsi K.

Gynecol Oncol. 2005 Oct;99(1):183-8.

PMID:
16005946
31.

Cyclooxygenase 2 expression in serous tumors of the ovary.

Singhal PK, Spiegel G, Driscoll D, Odunsi K, Lele S, Rodabaugh KJ.

Int J Gynecol Pathol. 2005 Jan;24(1):62-6.

PMID:
15626918
32.

Response of combination platinum and gemcitabine chemotherapy for recurrent epithelial ovarian carcinoma.

Villella J, Marchetti D, Odunsi K, Rodabaugh K, Driscoll DL, Lele S.

Gynecol Oncol. 2004 Dec;95(3):539-45.

PMID:
15581960
33.

SCP-1 cancer/testis antigen is a prognostic indicator and a candidate target for immunotherapy in epithelial ovarian cancer.

Tammela J, Jungbluth AA, Qian F, Santiago D, Scanlan MJ, Keitz B, Driscoll D, Rodabaugh K, Lele S, Old LJ, Odunsi K.

Cancer Immun. 2004 Oct 18;4:10.

34.

Analysis of the time interval between diagnoses in women with double primary breast and ovarian or primary peritoneal cancers.

Olawaiye A, Caesar L, Walsh D, Lyman M, Yeh J, Rodabaugh K, Marchetti D, Lele S, Odunsi K.

Gynecol Oncol. 2004 Sep;94(3):796-802.

PMID:
15350375
35.

Antioxidant inhibits tamoxifen-DNA adducts in endometrial explant culture.

Sharma M, Shubert DE, Sharma M, Rodabaugh KJ, McGarrigle BP, Vezina CM, Bofinger DP, Olson JR.

Biochem Biophys Res Commun. 2003 Jul 18;307(1):157-64.

PMID:
12849995
36.

Breast cancer prevention.

Rodabaugh KJ, Bloss JD.

Clin Obstet Gynecol. 2001 Sep;44(3):478-84. Review. No abstract available.

PMID:
11685873
37.

Custody planning. a retrospective review of oncology patients who were single parents.

Willis L, Peck M, Sells S, Rodabaugh KJ.

J Pain Symptom Manage. 2001 May;21(5):380-4.

PMID:
11369158
38.

A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas.

Colitti CV, Rodabaugh KJ, Welch WR, Berkowitz RS, Mok SC.

Oncogene. 1998 Jan 29;16(4):555-9.

39.

Natural history of postterm choriocarcinoma.

Rodabaugh KJ, Bernstein MR, Goldstein DP, Berkowitz RS.

J Reprod Med. 1998 Jan;43(1):75-80.

PMID:
9475153
40.

Detailed deletion mapping of chromosome 9p and p16 gene alterations in human borderline and invasive epithelial ovarian tumors.

Rodabaugh KJ, Biggs RB, Qureshi JA, Barrett AJ, Welch WR, Bell DA, Berkowitz RS, Mok SC.

Oncogene. 1995 Oct 5;11(7):1249-54.

PMID:
7478544
41.

Detailed deletion mapping of chromosome 6q in borderline epithelial ovarian tumors.

Rodabaugh KJ, Blanchard G, Welch WR, Bell DA, Berkowitz RS, Mok SC.

Cancer Res. 1995 May 15;55(10):2169-72.

42.

Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-alpha.

Wu S, Rodabaugh K, Martinez-Maza O, Watson JM, Silberstein DS, Boyer CM, Peters WP, Weinberg JB, Berek JS, Bast RC Jr.

Am J Obstet Gynecol. 1992 Mar;166(3):997-1007.

PMID:
1550178

Supplemental Content

Loading ...
Support Center